Skip to main content
. 2018 May 15;9(37):24684–24692. doi: 10.18632/oncotarget.25227

Figure 1. Diagnostic values of the individual panels of biomarkers and integromic plasma signature in a development cohort.

Figure 1

The integromic plasma biomarker signature yields a higher area under receiver operating characteristic curve (AUC) than does individual panels of biomarkers (All p<0.05).